SETD2 loss sensitizes kidney cancer cells to DNA hypomethylating agents [methylation]. SETD2 loss sensitizes kidney cancer cells to DNA hypomethylating agents [methylation]
收藏NIAID Data Ecosystem2026-03-14 收录
官方服务：
资源简介：
Genome-wide DNA methylation profiling of SETD2-null 786-0 RCC cells treated with decitabine (100nM and 300nM) or DMSO vehicle. The Illumina Infinium HumanMethylation EPIC BeadChip was used to obtain DNA methylation profiles across approximately 850K CpGs. Overall design: Bisulfite converted DNA from 6 samples were hybridized to the Illumina Infinium HumanMethylation EPIC BeadChip
创建时间：
2023-01-25
